Bonnie J. Addario Lung Cancer Foundation Joins Lung-MAP, Collaborative Group Multi-Drug, Biomarker-Driven Clinical Trial For Lung Cancer
6/16/2014 10:36:11 AM
SAN CARLOS, Calif.--(BUSINESS WIRE)--The Bonnie J. Addario Lung Cancer Foundation (ALCF) has signed on as a collaborating organization with the Lung Cancer Master Protocol (Lung-MAP) clinical trial, which will use genomic profiling to match patients to one of several different investigational treatments that are designed to target the genomic alterations found to be driving the growth of their cancer. This innovative approach to clinical testing should both improve access to promising drugs for patients and ease the significant recruitment and infrastructure burdens on researchers involved in traditional clinical trials.
Help employers find you! Check out all the jobs and post your resume.
comments powered by